Levodopa/Carbidopa/Entacapone Lannacher 50 mg/12,5 mg/200 mg filmomhulde tabletten

Nchi: Uholanzi

Lugha: Kiholanzi

Chanzo: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

Viambatanisho vya kazi:

CARBIDOPA 1-WATER 13,5 mg/stuk SAMENSTELLING overeenkomend met ; CARBIDOPA 0-WATER 12,5 mg/stuk ; ENTACAPONE 200 mg/stuk ; LEVODOPA 50 mg/stuk

Inapatikana kutoka:

Lannacher Heilmittel GmbH Schlossplatz 1 A-8502 LANNACH (OOSTENRIJK)

ATC kanuni:

N04BA03

INN (Jina la Kimataifa):

CARBIDOPA 1-WATER 13,5 mg/stuk SAMENSTELLING overeenkomend met ; CARBIDOPA 0-WATER 12,5 mg/stuk ; ENTACAPONE 200 mg/stuk ; LEVODOPA 50 mg/stuk

Dawa fomu:

Filmomhulde tablet

Tungo:

CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; CROSCARMELLOSE NATRIUM (E 468) ; GLYCEROL (E 422) ; HYPROLOSE (E 463) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; POLOXAMEER 188 ; POLYSORBAAT 80 (E 433) ; TITAANDIOXIDE (E 171), CELLULOSE, MICROKRISTALLIJN (E 460) ; CROSCARMELLOSE NATRIUM (E 468) ; GLYCEROL (E 422) ; HYPROLOSE (E 463) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; POLOXAMEER 188 ; POLYSORBAAT 80 (E 433) ; TITAANDIOXIDE (E 171),

Njia ya uendeshaji:

Oraal gebruik

Eneo la matibabu:

Levodopa, Decarboxylase Inhibitor And Comt Inhibitor

Bidhaa muhtasari:

Hulpstoffen: CELLULOSE, MICROKRISTALLIJN (E 460); CROSCARMELLOSE NATRIUM (E 468); GLYCEROL (E 422); HYPROLOSE (E 463); HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464); IJZEROXIDE GEEL (E 172); IJZEROXIDE ROOD (E 172); LACTOSE 1-WATER; MAGNESIUMSTEARAAT (E 470b); POLOXAMEER 188; POLYSORBAAT 80 (E 433); TITAANDIOXIDE (E 171);

Idhini ya tarehe:

1900-01-01

Taarifa za kipeperushi

PACKAGE LEAFLET: INFORMATION FOR THE USER
LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 50 MG/12,5 MG/200 MG
FILMOMHULDE TABLETTEN
LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 75 MG/18,75 MG/200 MG
FILMOMHULDE TABLETTEN
LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 100 MG/25MG/200 MG FILMOMHULDE
TABLETTEN
LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 125 MG/31,25 MG/200 MG
FILMOMHULDE TABLETTEN
LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 150 MG/37,5 MG/200 MG
FILMOMHULDE TABLETTEN
LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 175 MG/43,75 MG/200 MG
FILMOMHULDE TABLETTEN
LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 200 MG/50 MG/200 MG
FILMOMHULDE TABLETTEN
levodopa/carbidopa/entacapone
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their symptoms of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Levodopa/Carbidopa/Entacapone Lannacher is and what it is used
for
2.
What you need to know before you take Levodopa/Carbidopa/Entacapone
Lannacher
3.
How to take Levodopa/Carbidopa/Entacapone Lannacher
4.
Possible side effects
5.
How to store Levodopa/Carbidopa/Entacapone Lannacher
6.
Contents of the pack and other information
1.
WHAT LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER IS AND WHAT IT IS USED
FOR
Levodopa/Carbidopa/Entacapone Lannacher contains three active
substances (levodopa,
carbidopa and entacapone) in one film-coated tablet.
Levodopa/Carbidopa/Entacapone Lannacher
is used for the treatment of Parkinson’s disease.
Parkinson’s disease is caused by low levels of a substance called
dopamine in the brain.
Levodopa increases the amount of dopamine and hence reduces the
symptoms of Parkinson�

Tabia za bidhaa

1.
NAME OF THE MEDICINAL PRODUCT
Levodopa/Carbidopa/Entacapone Lannacher 50 mg/12,5 mg/200 mg
filmomhulde tabletten
Levodopa/Carbidopa/Entacapone Lannacher 75 mg/18,75 mg/200 mg
filmomhulde tabletten
Levodopa/Carbidopa/Entacapone Lannacher 100 mg/25mg/200 mg filmomhulde
tabletten
Levodopa/Carbidopa/Entacapone Lannacher 125 mg/31,25 mg/200 mg
filmomhulde tabletten
Levodopa/Carbidopa/Entacapone Lannacher 150 mg/37,5 mg/200 mg
filmomhulde tabletten
Levodopa/Carbidopa/Entacapone Lannacher 175 mg/43,75 mg/200 mg
filmomhulde tabletten
Levodopa/Carbidopa/Entacapone Lannacher 200 mg/50 mg/200 mg
filmomhulde tabletten
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 50 mg of levodopa, 12.5 mg of
carbidopa anhydrous (as 13.5mg
Carbidopa monohydrate) and 200 mg of entacapone.
Each film-coated tablet contains 75 mg of levodopa, 18.75 mg of
carbidopa anhydrous (as 20.24
mg Carbidopa monohydrate) and 200 mg of entacapone.
Each film-coated tablet contains 100 mg of levodopa, 25 mg of
carbidopa anhydrous (as 27 mg
Carbidopa monohydrate) and 200 mg of entacapone.
Each film-coated tablet contains 125 mg of levodopa, 31.25 mg of
carbidopa anhydrous (as 33.74
mg Carbidopa monohydrate) and 200 mg of entacapone.
Each film-coated tablet contains 150 mg of levodopa, 37.5 mg of
carbidopa anhydrous (as 40.48
mg Carbidopa monohydrate) and 200 mg of entacapone.
Each film-coated tablet contains 175 mg of levodopa, 43.75 mg of
carbidopa anhydrous (as 47.23
mg Carbidopa monohydrate) and 200 mg of entacapone.
Each film-coated tablet contains 200 mg of levodopa, 50 mg of
carbidopa anhydrous (as 54 mg
Carbidopa monohydrate) and 200 mg of entacapone.
Excipient with known effect:
Each film-coated tablet of 50 mg levodopa/12.5 mg carbidopa
anhydrous/200 mg entacapone
contains 112 mg of lactose
Each film-coated tablet of 75 mg/levodopa/18.75 mg of carbidopa
anhydrous/200 mg entacapone
contains 124 mg of lactose .
Each film-coated tablet of 100 mg levodopa/25 mg of carbidopa
anhydrous/200 mg entacapone
contains 139 mg of la